The paroxysm of Plasmodium vivax malaria

被引:52
|
作者
Karunaweera, ND
Wijesekera, SK
Wanasekera, D
Mendis, KN
Carter, R
机构
[1] Univ Colombo, Fac Med, Dept Parasitol, Colombo 8, Sri Lanka
[2] World Hlth Org, Roll Back Malaria Project, Geneva 27, Switzerland
[3] Univ Edinburgh, Div Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland
关键词
D O I
10.1016/S1471-4922(03)00036-9
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
The paroxysms of Plasmodium vivax malaria are antiparasite responses that, although distressing to the human host, almost never impart serious acute pathology. Using plasma and blood cells from P. vivax patients, the cellular and noncellular mediators of these events have been studied ex vivo. The host response during a A vivax paroxysm was found to involve T cells, monocytes and neutrophils, and the activity, among others, of the pyrogenic cytokines tumor necrosis factor a and interleukin 2 in addition to granulocyte macrophage-colony stimulating factor. However, interferon, gamma activity, associated with serious acute pathogenesis in other studies on malaria, was absent. Induction of the cytokines active during a P. vivax paroxysm depends upon the presence of parasite products, which are released into the plasma before the paroxysm. Chemical identification of these natural parasite products will be important for our understanding of pathogenesis and protection in malaria.
引用
收藏
页码:188 / 193
页数:6
相关论文
共 50 条
  • [31] Severe Plasmodium vivax Malaria in Pakistan
    Zubairi, Ali Bin Sarwar
    Nizami, Sobia
    Raza, Afsheen
    Mehraj, Vikram
    Rasheed, Anita Fazal
    Ghanchi, Najia Karim
    Khaled, Zahra Nur
    Beg, M. Asim
    EMERGING INFECTIOUS DISEASES, 2013, 19 (11) : 1851 - 1854
  • [32] NEONATAL MALARIA DUE TO PLASMODIUM VIVAX
    WOODS, WG
    MILLS, E
    FERRIERI, P
    JOURNAL OF PEDIATRICS, 1974, 85 (05): : 669 - 671
  • [33] Tafenoquine for the treatment of Plasmodium vivax malaria
    Llanos-Cuentas, Alejandro
    Manrrique, Paulo
    Rosas-Aguirre, Angel
    Herrera, Sonia
    Hsiang, Michelle S.
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (07) : 759 - 768
  • [34] Epidemiology of Plasmodium vivax Malaria in India
    Anvikar, Anupkumar R.
    Shah, Naman
    Dhariwal, Akshay C.
    Sonal, Gagan Singh
    Pradhan, Madan Mohan
    Ghosh, Susanta K.
    Valecha, Neena
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 95 (06): : 108 - 120
  • [35] Plasmodium vivax malaria vaccine development
    Arévalo-Herrera, M
    Herrera, S
    MOLECULAR IMMUNOLOGY, 2001, 38 (06) : 443 - 455
  • [36] Splenic Infarction in Plasmodium vivax Malaria
    Taneja, Sunil
    Mittal, Purvi
    INDIAN PEDIATRICS, 2014, 51 (04) : 320 - 320
  • [37] Epidemiology of Plasmodium vivax Malaria in Peru
    Rosas-Aguirre, Angel
    Gamboa, Dionicia
    Manrique, Paulo
    Conn, Jan E.
    Moreno, Marta
    Lescano, Andres G.
    Sanchez, Juan F.
    Rodriguez, Hugo
    Silva, Hermann
    Llanos-Cuentas, Alejandro
    Vinetz, Joseph M.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 95 (06): : 133 - 144
  • [38] Hemophagocytic syndrome in Plasmodium vivax malaria
    Pothapregada, Sriram
    Kamalakannan, Banupriya
    JOURNAL OF VECTOR BORNE DISEASES, 2014, 51 (02) : 144 - 146
  • [39] The neglected burden of Plasmodium vivax malaria
    Mendis, K
    Sina, BJ
    Marchesini, P
    Carter, R
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2001, 64 (1-2): : 97 - 106
  • [40] Development of vaccines for Plasmodium vivax malaria
    Mueller, Ivo
    Shakri, Ahmad Rushdi
    Chitnis, Chetan E.
    VACCINE, 2015, 33 (52) : 7489 - 7495